CCL5 might be a prognostic biomarker and associated with immuno-therapeutic efficacy in cancers: A pan-cancer analysis.

Yanchun Huang, Lijuan Wu,Yong Sun, Jiwen Li,Nan Mao, Yeqing Yang,Ming Zhao,Sichong Ren

Heliyon（2023）

引用 0|浏览6

暂无评分

摘要

In conclusion, CCL5 was preliminarly identified as a biomarker of immune response and prognosis for tumors patients via our first comprehensive pan-cancer analysis.

查看译文

关键词

prognostic biomarker,cancers,immuno-therapeutic,pan-cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要